CU Healthcare Innovation Fund

Clarapath, Inc. specializes in digital pathology by providing imaging and analysis services that enhance the processing of human and animal tissue for pathological review. The company has developed Section Star, an automated device that streamlines the microtomy process using a tape transfer method, which helps to standardize tissue sectioning and reduce variability. Clarapath offers a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory serves academic researchers, clinical laboratories, and physicians, aiming to improve lab efficiency and accuracy while maintaining robust safety standards. Founded in 2011 and headquartered in New York, Clarapath focuses on automating laboratory workflows to facilitate faster and more precise results for both research and clinical applications.

Q32 Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for severe autoimmune and inflammatory diseases. Established in 2017, the company aims to address immune system dysregulation, providing treatment options for conditions that currently have limited or inadequate therapies. Q32 Bio's pipeline includes ADX-914, a human anti-IL-7R antibody designed to re-regulate adaptive immune function, and ADX-097, which demonstrates effective distribution to affected tissues and robust efficacy. With a team of experienced scientists and industry professionals, Q32 Bio is dedicated to restoring healthy immune balance through novel biologic therapies that target critical pathways in both the innate and adaptive immune systems.

Vytyl Health Management delivers quality mental health care to adolescents and transitional-age youth. The organization firmly believes that connection forms the basis for healing. They recognize the significant challenges ahead but remain steadfast in their conviction that through collaborative efforts, barriers can be overcome, meaningful bonds can be formed, and vital assistance can be extended to those in greatest need.

Foresight Diagnostics specializes in developing innovative liquid biopsy tests aimed at measuring minimal residual disease, which assists in patient management for cancer care. The company’s technology enables early cancer detection through a simple blood sample, utilizing the unique biological characteristics that differentiate cancer cells from healthy cells. This approach allows healthcare professionals to identify smaller tumors earlier and implement personalized treatment strategies tailored to individual patients. Foresight Diagnostics has attracted considerable interest from multiple pharmaceutical companies in the oncology sector, indicating a strong potential for collaboration and advancement in cancer diagnosis and treatment.

ClinOne, Inc. is a clinical trial management solution that develops a mobile application designed to enhance communication and streamline workflow among researchers, investigators, and research staff. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne’s platform provides web and mobile access to essential clinical trial information, facilitating better interaction and engagement between researchers and patients. The application aims to improve clinical trial enrollment, retention, compliance at research sites, and overall patient experience. ClinOne offers a comprehensive suite of mobile technologies that centralize research efforts and deliver pertinent trial content to participants. Its clientele includes notable organizations such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

CodaMetrix is a developer of an AI-powered platform focused on automating healthcare revenue cycle management and medical coding. The platform utilizes machine learning, deep learning, and natural language processing to accurately translate clinical notes into billing and diagnostic codes. This automation not only meets coding requirements but also significantly reduces the workload for human coders. By continuously learning from clinical evidence within electronic health records and drawing from a comprehensive library of data points from national health systems, CodaMetrix enhances coding efficiency and quality, ultimately allowing healthcare providers to optimize their operations.

Sensorium Therapeutics is a drug discovery platform based in Boston, Massachusetts, that focuses on developing novel FDA-approved psychoactive medicines. Founded in 2021, the company utilizes an artificial intelligence product engine to discover and develop drugs targeting central nervous system diseases. By integrating historical human efficacy data from natural compounds, Sensorium Therapeutics aims to create new medicines characterized by innovative pharmacology and improved clinical success rates. This approach enables pharmaceutical companies to enhance their drug development processes effectively.

Carta Healthcare, Inc. is a technology company that provides a software-as-a-service platform designed to improve patient care in hospitals. Founded in 2016 and headquartered in San Mateo, California, the platform leverages existing IT data to describe patient journeys and predict potential bottlenecks, such as recovery bed shortages and cancellations. By employing machine learning, Carta Healthcare enables hospitals to personalize care, allowing them to identify past patients with similar profiles and analyze their experiences. This approach enhances the efficiency and quality of healthcare data management by combining artificial intelligence with skilled human expertise, facilitating more effective and cost-efficient data abstraction for health systems.

Eon Health is a healthcare technology company based in Denver, Colorado, that specializes in software solutions designed to enhance complex patient management. Founded in 2015 as Matrix Analytics and rebranded in 2018, Eon Health focuses on improving the way healthcare data is gathered, curated, and shared among professionals. Its EonDirect software platform integrates with hospitals' existing electronic health record (EHR) and electronic medical record (EMR) systems, providing an online dashboard that aids healthcare providers in diagnosing and treating complex diseases. The company currently collaborates with 31 hospitals to manage over 12,000 patients, ensuring that critical data is accessible to the right professionals at the right time.

Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Established in 2020 and based in Nashville, Tennessee, the company seeks to improve the affordability, accessibility, and patient-centricity of cancer care. By collaborating with healthcare systems and independent oncology practices, Reimagine Care supports value-based oncology care delivery. Their approach involves providing the necessary personnel, processes, and a comprehensive technology platform that facilitates the effective and scalable delivery of high-quality cancer care at various locations, including patients' homes. This model aims to enable patients to receive treatment and supportive care in a more convenient and cost-effective manner.

GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.

Cured, Inc. is a healthcare technology company that specializes in developing digital marketing tools and customer relationship management platforms for the healthcare sector. Founded in 2018 and headquartered in San Francisco, with additional offices in Chicago and Denver, Cured offers solutions that connect health systems and organizations to patients and their families. The company's cloud-based platform focuses on network management, patient marketing, and customer experience, providing design and product development services that address the unique challenges faced by healthcare and life sciences organizations. By leveraging modern business tools and integrating contact centers with electronic medical records, Cured enables clients to enhance brand awareness, improve patient satisfaction, and create engaging digital experiences that foster better healthcare behaviors and outcomes.

Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.

Carta Healthcare, Inc. is a technology company that provides a software-as-a-service platform designed to improve patient care in hospitals. Founded in 2016 and headquartered in San Mateo, California, the platform leverages existing IT data to describe patient journeys and predict potential bottlenecks, such as recovery bed shortages and cancellations. By employing machine learning, Carta Healthcare enables hospitals to personalize care, allowing them to identify past patients with similar profiles and analyze their experiences. This approach enhances the efficiency and quality of healthcare data management by combining artificial intelligence with skilled human expertise, facilitating more effective and cost-efficient data abstraction for health systems.

Riva Health is focused on advancing cardiovascular healthcare through innovative technology. The company has developed a digital therapeutics application that enables users to monitor hypertension using their smartphone's camera and graphics processing capabilities. By employing a technique known as photoplethysmography, the app allows individuals to measure their blood pressure conveniently from home, addressing a significant health concern given that heart disease is the leading cause of mortality in the United States. Co-founded by Dag Kittlaus and Tuhin Sinha, Riva Health aims to enhance the management of cardiovascular conditions through accessible and user-friendly solutions.

Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.

AristaMD is a healthcare company that features a software platform that helps hospitals and practitioners on improving patient outcomes. It also offers a solution that enables primary care providers to ask questions about patients that they would otherwise refer out and transmit patient clinical notes, history, lab results and images to collaborate on care plans with a panel of on-call, board-certified specialists, all within a matter of hours. The company was founded in 2013 and headquartered in La Jolla, California.

ClinOne, Inc. is a clinical trial management solution that develops a mobile application designed to enhance communication and streamline workflow among researchers, investigators, and research staff. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne’s platform provides web and mobile access to essential clinical trial information, facilitating better interaction and engagement between researchers and patients. The application aims to improve clinical trial enrollment, retention, compliance at research sites, and overall patient experience. ClinOne offers a comprehensive suite of mobile technologies that centralize research efforts and deliver pertinent trial content to participants. Its clientele includes notable organizations such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

IM Therapeutics develops personalized immunotherapeutic drugs for autoimmune diseases based on the genetic risk attributed by human leukocyte antigen (HLA) genes. Their lead candidate drug is an oral drug that starves the autoimmune process in type 1 diabetes (T1D) by blocking DQ8 on specific immune cells. Their goal is to preserve pancreatic beta-cell function and maintain normal insulin production in at-risk and early-stage patients with type 1 diabetes. They are leveraging Their HLA platform to expand their pipeline beyond T1D, to include drug development for Celiac disease (gluten sensitivity) as well as potential additional autoimmune diseases. It was founded in 2015 and is headquartered in Aurora, Colorado.

Carta Healthcare, Inc. is a technology company that provides a software-as-a-service platform designed to improve patient care in hospitals. Founded in 2016 and headquartered in San Mateo, California, the platform leverages existing IT data to describe patient journeys and predict potential bottlenecks, such as recovery bed shortages and cancellations. By employing machine learning, Carta Healthcare enables hospitals to personalize care, allowing them to identify past patients with similar profiles and analyze their experiences. This approach enhances the efficiency and quality of healthcare data management by combining artificial intelligence with skilled human expertise, facilitating more effective and cost-efficient data abstraction for health systems.